ID
28328
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: CEC Hospitalisation for unstable angina Repeating form (Scheduled visits)
Mots-clés
Versions (4)
- 10/10/2017 10/10/2017 -
- 16/10/2017 16/10/2017 -
- 23/10/2017 23/10/2017 -
- 04/01/2018 04/01/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
4 janvier 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
CEC - Hospitalisation for unstable angina GSK study Chronic Coronary Heart Disease NCT00799903
CEC - Hospitalisation for unstable angina GSK study Chronic Coronary Heart Disease NCT00799903
Description
Hospitalisation for unstable angina - CEC Section
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1]
- C0680730
Description
Adjudication Ischemic discomfort at rest
Type de données
text
Alias
- UMLS CUI [1]
- C3898664
Description
adjudication ischemic discomfort at rest duration
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0443144
- UMLS CUI [1,2]
- C3898664
Description
criteria for unstable angina not met specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0002965
- UMLS CUI [1,2]
- C3897171
Description
criteria for MI met
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C3897171
- UMLS CUI [1,2]
- C0027051
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1]
- C3897493
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1,1]
- C0680730
- UMLS CUI [1,2]
- C0011008
Description
CEC Status
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1]
- C1444748
Description
[hidden]
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0449438
- UMLS CUI [1,2]
- C0540683
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0443172
Description
[hidden]
Type de données
integer
Alias
- UMLS CUI [1]
- C3166277
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1]
- C0011008
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1,1]
- C3166277
- UMLS CUI [1,2]
- C0011008
Description
[hidden]
Type de données
integer
Alias
- UMLS CUI [1]
- C3166277
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1]
- C0011008
Description
[hidden]
Type de données
date
Alias
- UMLS CUI [1,1]
- C3166277
- UMLS CUI [1,2]
- C0011008
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1]
- C0947611
Description
[hidden]
Type de données
text
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0237753
Description
Use SAE Sequence number from the corresponding SAE form (the last item on the form, in the "Non-Clinical" section) [hidden].
Type de données
text
Alias
- UMLS CUI [1]
- C0877248
Description
Copy Serious Adverse Event term from corresponding SAE form [hidden].
Type de données
text
Alias
- UMLS CUI [1,1]
- C1516728
- UMLS CUI [1,2]
- C2826934
Similar models
CEC - Hospitalisation for unstable angina GSK study Chronic Coronary Heart Disease NCT00799903
C0855329 (UMLS CUI-2)
(Comment:en)
(Comment:en)
C0855329 (UMLS CUI-2)
(Comment:en)
C0581603 (UMLS CUI-2)
(Comment:en)
C3898664 (UMLS CUI [1,2])
C3897171 (UMLS CUI [1,2])
C0027051 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C2826934 (UMLS CUI [1,2])